Table 5.
Base-case scenario results (deterministic)
| Discounted at 4% | Undiscounted | |||||
|---|---|---|---|---|---|---|
| PP | Control | Difference | PP | Control | Difference | |
| Effects | ||||||
| Life years | 17.766 | 17.763 | 0.003 | 34.092 | 34.081 | 0.011 |
| Life years with diabetes | 2.769 | 2.781 | −0.012 | 7.016 | 7.040 | −0.024 |
| Cum. Incident cases diabetes/1000a | 377.255 | 378.201 | −0.946 | 377.255 | 378.201 | −0.946 |
| Cum. Incident cases IHD/1000a | 279.448 | 279.788 | −0.34 | 279.448 | 279.788 | −0.34 |
| Cum. Incident cases stroke/1000a | 315.719 | 316.094 | −0.375 | 315.719 | 316.094 | −0.375 |
| QALYs | 15.117 | 15.106 | 0.011 | 28.483 | 28.464 | 0.019 |
| Costs [in 2020 € (DKK)] | ||||||
|---|---|---|---|---|---|---|
| Diabetes | 18,118 (135,305) | 18,193 (135,864) | −75 (−559) | 46,769 (349,272) | 46,926 (350,445) | −157 (−1173) |
| IHD | 2910 (21,732) | 2916 (21,774) | −6 (−43) | 7219 (53,915) | 7230 (53,997) | −11 (−82) |
| Stroke | 3642 (27,199) | 3649 (27,252) | −7 (−53) | 10,775 (80,465) | 10,791 (80,586) | −16 (−121) |
| Unrelated | 137,618 (1,027,739) | 137,602 (1,027,616) | 17 (124) | 336,862 (2,515,695) | 336,763 (2,514,958) | 99 (737) |
| Non-medical | 327,597 (2,446,504) | 327,536 (2,446,050) | 61 (454) | 652,691 (4,874,319) | 652,465 (4,872,636) | 225 (1684) |
| Interventiona | 7402 (55,277) | 5653 (42,215) | 1749 (13,062) | 7402 (55,277) | 5653 (42,215) | 1749 (13,062) |
| Informal care | 5581 (41,680) | 5582 (41,683) | 0 (−3) | 16,169 (120,753) | 16,164 (120,713) | 5 (41) |
| Productivity | 17,234 (128,703) | 17,236 (128,772) | −3 (−19) | 24,668 (184,221) | 24,670 (184,240) | −2 (−18) |
| TOTAL | 520,102 (3,884,138) | 518,366 (3,871,175) | 1736 (12,963) | 1,102,555 (8,233,918) | 1,100,663 (8,219,788) | 1892 (14,129) |
| ICUR | 158,798 (1,185,909) | 99,575 (743,632) | ||||
Cum. cumulative, DKK Danish krone, ICUR incremental cost-utility ratio, IHD ischemic heart disease, PP personalized plan, QALYs, quality-adjusted life years
aNot discounted